DE69834195D1 - Stabilisierte tramadol formulierungen mit verzögerter freisetzung - Google Patents
Stabilisierte tramadol formulierungen mit verzögerter freisetzungInfo
- Publication number
- DE69834195D1 DE69834195D1 DE69834195T DE69834195T DE69834195D1 DE 69834195 D1 DE69834195 D1 DE 69834195D1 DE 69834195 T DE69834195 T DE 69834195T DE 69834195 T DE69834195 T DE 69834195T DE 69834195 D1 DE69834195 D1 DE 69834195D1
- Authority
- DE
- Germany
- Prior art keywords
- tramadol
- stabilized
- matrix
- dosage form
- storage conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5160297P | 1997-07-02 | 1997-07-02 | |
PCT/US1998/014087 WO1999001111A1 (en) | 1997-07-02 | 1998-07-02 | Stabilized sustained release tramadol formulations |
US51602 | 2002-01-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69834195D1 true DE69834195D1 (de) | 2006-05-24 |
DE69834195T2 DE69834195T2 (de) | 2007-03-29 |
Family
ID=21972304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69834195T Expired - Lifetime DE69834195T2 (de) | 1997-07-02 | 1998-07-02 | Stabilisierte tramadol formulierungen mit verzögerter freisetzung |
Country Status (12)
Country | Link |
---|---|
US (2) | US6306438B1 (de) |
EP (1) | EP1009387B1 (de) |
JP (2) | JP3739410B2 (de) |
AT (1) | ATE322892T1 (de) |
AU (1) | AU8293498A (de) |
CA (1) | CA2270975C (de) |
CY (1) | CY1106112T1 (de) |
DE (1) | DE69834195T2 (de) |
DK (1) | DK1009387T3 (de) |
ES (1) | ES2263211T3 (de) |
PT (1) | PT1009387E (de) |
WO (1) | WO1999001111A1 (de) |
Families Citing this family (125)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL119660A (en) | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
WO1999001111A1 (en) * | 1997-07-02 | 1999-01-14 | Euro-Celtique, S.A. | Stabilized sustained release tramadol formulations |
DK1041987T3 (da) | 1997-12-22 | 2006-08-21 | Euro Celtique Sa | Oral farmaceutisk doseringsform omfattende en kombination af en opioid-agonist og naltrexon |
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
DE19901683B4 (de) * | 1999-01-18 | 2005-07-21 | Grünenthal GmbH | Analgetikum mit kontrollierter Wirkstofffreisetzung |
BR0013825A (pt) * | 1999-08-31 | 2002-07-23 | Gruenenthal Chemie | Formas de apresentação de tramadol |
RS50407B (sr) | 2000-02-08 | 2009-12-31 | Euro-Celtique S.A., | Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika |
JP4570725B2 (ja) * | 2000-04-05 | 2010-10-27 | 大塚製薬株式会社 | 医薬製剤用組成物 |
ES2361148T3 (es) | 2001-05-11 | 2011-06-14 | Endo Pharmaceuticals Inc. | Forma de dosificación de opioides de liberación controlada resistente al abuso. |
JP4310605B2 (ja) | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
JP2004534056A (ja) * | 2001-06-08 | 2004-11-11 | エンドー ファーマシューティカルズ, インコーポレイティド | アクリルポリマーを使用する制御放出投薬形態、およびそれを作製するためのプロセス |
EP1406630A1 (de) | 2001-07-06 | 2004-04-14 | Endo Pharmaceuticals Inc. | Parenterale verabreichung von hydroxy-oxymorphon als analgetikum |
US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
CA2454328C (en) | 2001-07-18 | 2008-03-18 | Christopher D. Breder | Pharmaceutical combinations of oxycodone and naloxone |
MXPA04001210A (es) | 2001-08-06 | 2004-07-08 | Euro Celtique Sa | Formulaciones de agonista opioide con antagonista liberable y aislado. |
WO2003013433A2 (en) | 2001-08-06 | 2003-02-20 | Euro-Celtique S.A. | Sequestered antagonist formulations |
US20030044458A1 (en) | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
US8460693B2 (en) * | 2001-11-08 | 2013-06-11 | Atrium Medical Corporation | Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent |
JP5069395B2 (ja) * | 2002-02-21 | 2012-11-07 | ヴァレアント インターナショナル (バルバドス) エスアールエル | トラマドールの少なくとも1つの形の放出が改良された医薬組成物 |
US8128957B1 (en) | 2002-02-21 | 2012-03-06 | Valeant International (Barbados) Srl | Modified release compositions of at least one form of tramadol |
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
US20050182056A9 (en) * | 2002-02-21 | 2005-08-18 | Seth Pawan | Modified release formulations of at least one form of tramadol |
CA2479252A1 (en) * | 2002-03-22 | 2003-10-02 | Cilag Ag | Sustained release formulation of tramadol |
CN102813654A (zh) | 2002-04-05 | 2012-12-12 | 欧洲凯尔蒂克公司 | 含有羟氢可待酮和烯丙羟吗啡酮的药物制剂 |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US10004729B2 (en) | 2002-07-05 | 2018-06-26 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
AR040682A1 (es) | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
PT1551372T (pt) | 2002-09-20 | 2018-07-23 | Alpharma Pharmaceuticals Llc | Subunidade de sequestração e composições e métodos relacionados |
US20050020613A1 (en) * | 2002-09-20 | 2005-01-27 | Alpharma, Inc. | Sustained release opioid formulations and method of use |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
KR101120729B1 (ko) * | 2002-10-25 | 2012-04-23 | 라보팜 인코포레이트 | 서방 조성물 |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
PT1594460E (pt) * | 2002-10-25 | 2008-06-27 | Labopharm Inc | Formulações de tramadol de libertação sustentada com eficácia durante 24 horas |
CN1942175B (zh) * | 2002-10-25 | 2010-05-26 | 莱博法姆公司 | 24小时有效的曲马多缓释制剂 |
DE10300325A1 (de) | 2003-01-09 | 2004-07-22 | Hexal Ag | Granulat mit öliger Substanz, Herstellungsverfahren und Tablette |
CN100500130C (zh) * | 2003-01-23 | 2009-06-17 | 株式会社太平洋 | 缓释制剂及其制备方法 |
EP1905435A3 (de) | 2003-03-11 | 2008-05-14 | Euro-Celtique S.A. | Titrationsdosierschema zur kontrollierten Abgabe von Tramadol |
US7413749B2 (en) * | 2003-03-11 | 2008-08-19 | Purdue Pharma L.P. | Titration dosing regimen for controlled release tramadol |
US20040202717A1 (en) | 2003-04-08 | 2004-10-14 | Mehta Atul M. | Abuse-resistant oral dosage forms and method of use thereof |
MY135852A (en) | 2003-04-21 | 2008-07-31 | Euro Celtique Sa | Pharmaceutical products |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
ES2289542T3 (es) | 2003-08-06 | 2008-02-01 | Grunenthal Gmbh | Forma farmaceutica protegida contra un posible abuso. |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
GB0501638D0 (en) * | 2005-01-28 | 2005-03-02 | Euro Celtique Sa | Particulates |
EP1604666A1 (de) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit |
EP1604667A1 (de) * | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioide zur Behandlung des Restless Leg Syndroms |
EP1765292B1 (de) | 2004-06-12 | 2017-10-04 | Collegium Pharmaceutical, Inc. | Gegen missbrauch gesicherte arzneimittelformulierungen |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
CA2572928A1 (en) * | 2004-07-22 | 2006-02-26 | Amorepacific Corporation | Sustained-release preparations containing topiramate and the producing method thereof |
PL1781260T5 (pl) | 2004-08-13 | 2014-09-30 | Boehringer Ingelheim Int | Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól, sposób wytwarzania tego preparatu i jego zastosowanie |
UA88477C2 (ru) | 2004-08-13 | 2009-10-26 | Бёрингер Ингельхайм Интернациональ Гмбх | Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение |
US20060067976A1 (en) | 2004-09-28 | 2006-03-30 | Atrium Medical Corporation | Formation of barrier layer |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
MX2007009162A (es) * | 2005-01-28 | 2007-10-23 | Euro Celtique Sa | Formas de dosis rsistente al alcohol. |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
EP1702558A1 (de) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Verfahren und Vorrichtung zur Darmtätigkeitserfassung |
EP1695700A1 (de) * | 2005-02-28 | 2006-08-30 | Euro-Celtique S.A. | Darreichungsform enthaltend Oxycodon und Naloxon |
CA2578626C (en) | 2005-06-27 | 2011-07-19 | Biovail Laboratories International S.R.L. | Modified-release formulations of a bupropion salt |
CA2615802C (en) | 2005-07-07 | 2015-10-06 | Farnam Companies, Inc. | Sustained release pharmaceutical compositions for highly water soluble drugs |
RU2385712C2 (ru) * | 2005-08-24 | 2010-04-10 | Рубикон Рисёч Пвт Лтд. | Рецептура с контролируемым высвобождением |
US8795723B2 (en) | 2005-09-09 | 2014-08-05 | Angelini Pharma Inc. | Sustained drug release compositions |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
PL116330U1 (en) * | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
CN1957909B (zh) * | 2005-10-31 | 2013-09-11 | 阿尔扎公司 | 降低鸦片样物质持续释放口服剂型的由醇诱导的剂量突然释放的方法 |
EP1849460A3 (de) * | 2005-10-31 | 2007-11-14 | ALZA Corporation | Verfahren zur Reduktion der Alkohol induzierten Dosis Sturzentleerung oraler Zubereitungen mit verzögerter Freisetzung von Opioiden |
CA2882048C (en) | 2006-02-03 | 2020-03-24 | Proventiv Therapeutics, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
US20070190141A1 (en) * | 2006-02-16 | 2007-08-16 | Aaron Dely | Extended release opiate composition |
EP2526932B1 (de) | 2006-06-19 | 2017-06-07 | Alpharma Pharmaceuticals LLC | Pharmazeutische Zusammensetzung |
ES2497494T3 (es) | 2006-06-21 | 2014-09-23 | Opko Renal, Llc | Método de tratamiento y prevención del hiperparatiroidismo secundario |
CN101500611A (zh) * | 2006-06-23 | 2009-08-05 | 埃斯蒂维实验室股份有限公司 | 胆碱脂酶抑制剂与具有5-ht6受体亲和力的化合物的组合 |
SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
WO2009047644A2 (en) | 2007-04-25 | 2009-04-16 | Cytochroma Inc. | Method of treating vitamin d insufficiency and deficiency |
KR20190028822A (ko) | 2007-04-25 | 2019-03-19 | 사이토크로마 인코포레이티드 | 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
US20080318994A1 (en) | 2007-06-21 | 2008-12-25 | Endo Pharmaceuticals, Inc. | Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment |
US8623418B2 (en) | 2007-12-17 | 2014-01-07 | Alpharma Pharmaceuticals Llc | Pharmaceutical composition |
AU2009207796B2 (en) | 2008-01-25 | 2014-03-27 | Grunenthal Gmbh | Pharmaceutical dosage form |
US20090246276A1 (en) * | 2008-01-28 | 2009-10-01 | Graham Jackson | Pharmaceutical Compositions |
BRPI0912014A2 (pt) | 2008-05-09 | 2019-03-06 | Grünenthal GmbH | processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização |
US20100003322A1 (en) * | 2008-07-03 | 2010-01-07 | Lai Felix S | Enteric coated hydrophobic matrix formulation |
US20120065221A1 (en) | 2009-02-26 | 2012-03-15 | Theraquest Biosciences, Inc. | Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use |
WO2010103039A1 (en) | 2009-03-10 | 2010-09-16 | Euro-Celtique S.A. | Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
RU2015138422A (ru) | 2009-07-22 | 2018-12-25 | Грюненталь Гмбх | Стабильная при окислении, прочная на излом лекарственная форма |
CA2765971C (en) | 2009-07-22 | 2017-08-22 | Gruenenthal Gmbh | Hot-melt extruded controlled release dosage form |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
US10668060B2 (en) | 2009-12-10 | 2020-06-02 | Collegium Pharmaceutical, Inc. | Tamper-resistant pharmaceutical compositions of opioids and other drugs |
US9579285B2 (en) | 2010-02-03 | 2017-02-28 | Gruenenthal Gmbh | Preparation of a powdery pharmaceutical composition by means of an extruder |
SG183993A1 (en) * | 2010-03-09 | 2012-10-30 | Alkermes Pharma Ireland Ltd | Alcohol resistant enteric pharmaceutical compositions |
PT2552484T (pt) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Métodos e composições para redução dos níveis de parafróides |
CN103002881B (zh) | 2010-05-10 | 2015-09-02 | 欧洲凯尔特公司 | 载有活性剂的颗粒与额外活性剂的组合 |
CH705273B1 (de) | 2010-05-10 | 2016-06-15 | Euro Celtique Sa | Pharmazeutische Zusammensetzung – umfassend Hydromorphon und Naloxon. |
AU2011252040C1 (en) | 2010-05-10 | 2015-04-02 | Euro-Celtique S.A. | Manufacturing of active-free granules and tablets comprising the same |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
PL2611426T3 (pl) | 2010-09-02 | 2014-09-30 | Gruenenthal Gmbh | Postać dawkowania zawierająca nieorganiczne sole, odporna na zgniatanie |
WO2012028318A1 (en) | 2010-09-02 | 2012-03-08 | Grünenthal GmbH | Tamper resistant dosage form comprising an anionic polymer |
US10201502B2 (en) | 2011-07-29 | 2019-02-12 | Gruenenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
EP2736497B1 (de) | 2011-07-29 | 2017-08-23 | Grünenthal GmbH | Verfälschungssichere multipartikel-tablette, die eine sofortige wirkstofffreigabe bereitstellt |
US20130225697A1 (en) | 2012-02-28 | 2013-08-29 | Grunenthal Gmbh | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
MX362357B (es) | 2012-04-18 | 2019-01-14 | Gruenenthal Gmbh | Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis. |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
WO2014191397A1 (en) | 2013-05-29 | 2014-12-04 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
AR096439A1 (es) | 2013-05-29 | 2015-12-30 | Gruenenthal Gmbh | Forma de dosificación resistente al uso indebido que contiene una o más partículas |
EA032465B1 (ru) | 2013-07-12 | 2019-05-31 | Грюненталь Гмбх | Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления |
CA2918004C (en) | 2013-07-23 | 2018-11-20 | Euro-Celtique S.A. | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
WO2015037019A2 (en) * | 2013-09-15 | 2015-03-19 | Rubicon Research Private Limited | Modified release pharmaceutical formulations |
UA116405C2 (uk) | 2013-11-13 | 2018-03-12 | Євро-Селтік С.А. | Гідроморфон та налоксон для лікування болю та синдрому опіоїдної дисфункції кишечнику |
CN105934241B (zh) | 2013-11-26 | 2020-06-05 | 格吕伦塔尔有限公司 | 通过低温研磨制备粉末状药物组合物 |
JP2017518980A (ja) | 2014-05-12 | 2017-07-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | タペンタドールを含む、改変防止即時放出カプセル製剤 |
WO2015181059A1 (en) | 2014-05-26 | 2015-12-03 | Grünenthal GmbH | Multiparticles safeguarded against ethanolic dose-dumping |
EP3193925A2 (de) | 2014-08-07 | 2017-07-26 | OPKO Ireland Global Holdings, Ltd. | Adjunktive therapie mit 25-hydroxyvitamin d |
EP3285745A1 (de) | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Manipulationssichere darreichungsform mit sofortiger freisetzung und widerstand gegen lösungsmittelextraktion |
FR3037789A1 (fr) * | 2015-06-23 | 2016-12-30 | Rondol Ind | Ligne de production pour la production de medicaments, et installation de production comprenant une telle ligne de production |
EP3346991A1 (de) | 2015-09-10 | 2018-07-18 | Grünenthal GmbH | Schutz vor oraler überdosierung mit missbrauchssicheren formulierungen mit sofortiger freisetzung |
IL290855B1 (en) | 2016-03-28 | 2024-02-01 | Eirgen Pharma Ltd | Treatment methods using vitamin D |
WO2017222575A1 (en) | 2016-06-23 | 2017-12-28 | Collegium Pharmaceutical, Inc. | Process of making more stable abuse-deterrent oral formulations |
EP3703724A1 (de) | 2017-11-02 | 2020-09-09 | NatureCeuticals Sdn. Bhd. | Extrakt aus orthosiphon stamineus, formulierungen und verwendungen davon |
EP3846852A4 (de) * | 2018-09-07 | 2022-06-15 | R.P. Scherer Technologies, LLC | Feste oder halbfeste lipidbasierte darreichungsform durch härtung und zusatz von tensid(en) mit niedrigem hlb-gehalt |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3870790A (en) | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
US3901968A (en) | 1973-09-10 | 1975-08-26 | Union Corp | Sustained release of methantheline |
US3901969A (en) | 1973-09-10 | 1975-08-26 | Union Corp | Sustained release of methantheline |
US4088798A (en) | 1975-11-11 | 1978-05-09 | Sandoz, Inc. | Methods for the preparation of controlled gastric residence time medicament formulations |
GB1561204A (en) | 1977-06-01 | 1980-02-13 | Ici Ltd | Sustained release pharmaceutical composition |
DE2904310A1 (de) | 1979-02-05 | 1980-08-07 | Boehringer Mannheim Gmbh | Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung |
US4548990A (en) | 1983-08-15 | 1985-10-22 | Ciba-Geigy Corporation | Crosslinked, porous polymers for controlled drug delivery |
IE56999B1 (en) | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
JPS60166608A (ja) | 1984-02-08 | 1985-08-29 | Japan Atom Energy Res Inst | サンドイツチ構造をもつ徐放性複合体およびその製造方法 |
WO1985003436A1 (en) | 1984-02-10 | 1985-08-15 | A/S Alfred Benzon | Diffusion coated multiple-units dosage form |
US4795327A (en) | 1984-03-26 | 1989-01-03 | Forest Laboratories, Inc. | Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants |
US4849229A (en) | 1984-03-26 | 1989-07-18 | Forest Laboratories, Inc. | Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants |
GB2170104A (en) | 1985-01-30 | 1986-07-30 | Warner Lambert Co | Coated pharmaceutical dosage forms |
US4600645A (en) | 1985-01-31 | 1986-07-15 | Warner-Lambert Company | Process for treating dosage forms |
US5186937A (en) | 1985-06-07 | 1993-02-16 | A.E.C. Societe De Chimie Organique Et Biologique | Composition for feeding ruminants |
GB8519310D0 (en) | 1985-07-31 | 1985-09-04 | Zyma Sa | Granular active substances |
GB8521494D0 (en) | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
IT1214629B (it) | 1985-08-29 | 1990-01-18 | Formenti Farmaceutici Spa | Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono |
US4837004A (en) | 1985-10-18 | 1989-06-06 | Eastman Kodak Company | Rumen-stable pellets |
IT1204294B (it) | 1986-03-11 | 1989-03-01 | Gentili Ist Spa | Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato |
US4756911A (en) | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4810501A (en) | 1986-06-17 | 1989-03-07 | Warner-Lambert Company | Sustained release pharmaceutical preparations |
GB8707416D0 (en) | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
JP2668880B2 (ja) | 1987-06-23 | 1997-10-27 | 日本油脂株式会社 | 被覆アミノ酸類の製造方法 |
US5068110A (en) | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
US5219621A (en) | 1987-10-16 | 1993-06-15 | Elan Corporation, Plc | Methods of treatment with diltiazem formulations |
FR2624732B1 (fr) | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
US4837033A (en) | 1987-12-22 | 1989-06-06 | Shin-Etsu Chemical Co., Ltd. | Method for the preparation of a coated solid medicament |
US5019397A (en) | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
US5024842A (en) | 1988-04-28 | 1991-06-18 | Alza Corporation | Annealed coats |
US5009897A (en) | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
US5085866A (en) | 1988-12-02 | 1992-02-04 | Southern Research Institute | Method of producing zero-order controlled-released devices |
CA2007181C (en) | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
CA2007055A1 (en) | 1989-01-06 | 1990-07-06 | Garth Boehm | Theophylline dosage form |
US5202128A (en) | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5122384A (en) | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
PH27186A (en) | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
JPH03232814A (ja) | 1990-02-08 | 1991-10-16 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
US5077053A (en) | 1990-02-12 | 1991-12-31 | Warner-Lambert Company | Zein as a moisture barrier for sugarless edible compositions and method for preparing same |
US5158777A (en) | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
CA2036907C (en) | 1990-02-28 | 1996-10-22 | Yuzo Miura | 3-(substituted phenyl) pyrazole derivatives, a process for producing the same, herbicidal composition containing the same and method of controlling weeds using said composition |
US5178866A (en) | 1990-03-23 | 1993-01-12 | Alza Corporation | Dosage form for delivering drug to the intestine |
JP2558396B2 (ja) | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
JPH04230625A (ja) | 1990-12-27 | 1992-08-19 | Standard Chem & Pharmaceut Corp Ltd | 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法 |
US5286497A (en) | 1991-05-20 | 1994-02-15 | Carderm Capital L.P. | Diltiazem formulation |
ZA923474B (en) | 1991-05-20 | 1993-01-27 | Marion Merrell Dow Inc | Diltiazem formulation |
US5288505A (en) | 1991-06-26 | 1994-02-22 | Galephar P.R., Inc., Ltd. | Extended release form of diltiazem |
US5213811A (en) | 1991-09-13 | 1993-05-25 | Sterling Drug Inc. | Oral sustained-release drug compositions |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5472712A (en) | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US5286493A (en) | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5273760A (en) | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5160742A (en) | 1991-12-31 | 1992-11-03 | Abbott Laboratories | System for delivering an active substance for sustained release |
IL119660A (en) | 1993-05-10 | 2002-09-12 | Euro Celtique Sa | Controlled release formulation comprising tramadol |
DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
JP3232814B2 (ja) | 1993-09-22 | 2001-11-26 | ジェイエスアール株式会社 | 感熱記録媒体用インキ組成物 |
AU682764B2 (en) | 1994-04-01 | 1997-10-16 | Tsumura & Co. | Process for producing sustained-release tablets and enteric tablets |
US5965161A (en) | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
WO1999001111A1 (en) * | 1997-07-02 | 1999-01-14 | Euro-Celtique, S.A. | Stabilized sustained release tramadol formulations |
-
1998
- 1998-07-02 WO PCT/US1998/014087 patent/WO1999001111A1/en active IP Right Grant
- 1998-07-02 DK DK98933239T patent/DK1009387T3/da active
- 1998-07-02 AU AU82934/98A patent/AU8293498A/en not_active Abandoned
- 1998-07-02 PT PT98933239T patent/PT1009387E/pt unknown
- 1998-07-02 CA CA002270975A patent/CA2270975C/en not_active Expired - Lifetime
- 1998-07-02 EP EP98933239A patent/EP1009387B1/de not_active Expired - Lifetime
- 1998-07-02 JP JP50747799A patent/JP3739410B2/ja not_active Expired - Lifetime
- 1998-07-02 ES ES98933239T patent/ES2263211T3/es not_active Expired - Lifetime
- 1998-07-02 AT AT98933239T patent/ATE322892T1/de active
- 1998-07-02 DE DE69834195T patent/DE69834195T2/de not_active Expired - Lifetime
- 1998-07-02 US US09/109,615 patent/US6306438B1/en not_active Expired - Lifetime
-
2001
- 2001-10-19 US US10/052,844 patent/US6645527B2/en not_active Expired - Lifetime
-
2003
- 2003-05-19 JP JP2003140053A patent/JP4576097B2/ja not_active Expired - Lifetime
-
2006
- 2006-07-03 CY CY20061100915T patent/CY1106112T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20020102302A1 (en) | 2002-08-01 |
CA2270975C (en) | 2003-04-01 |
WO1999001111A1 (en) | 1999-01-14 |
AU8293498A (en) | 1999-01-25 |
EP1009387B1 (de) | 2006-04-12 |
JP2004002419A (ja) | 2004-01-08 |
US6645527B2 (en) | 2003-11-11 |
EP1009387A1 (de) | 2000-06-21 |
JP2000510487A (ja) | 2000-08-15 |
US6306438B1 (en) | 2001-10-23 |
PT1009387E (pt) | 2006-08-31 |
EP1009387A4 (de) | 2004-08-25 |
DE69834195T2 (de) | 2007-03-29 |
ATE322892T1 (de) | 2006-04-15 |
ES2263211T3 (es) | 2006-12-01 |
JP3739410B2 (ja) | 2006-01-25 |
CY1106112T1 (el) | 2011-06-08 |
DK1009387T3 (da) | 2006-08-14 |
JP4576097B2 (ja) | 2010-11-04 |
CA2270975A1 (en) | 1999-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69834195D1 (de) | Stabilisierte tramadol formulierungen mit verzögerter freisetzung | |
NO881296D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk preparat. | |
DK0620731T3 (da) | Farmaceutisk præparat i form af en bruse- og/eller henfaldstablet eller et instantgranulat samt fremgangsmåde til fremstilling deraf | |
DE69022876D1 (de) | Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe. | |
SE8505099L (sv) | Pulver med reglerad frigoring samt sett for framstellning derav | |
DE3773468D1 (de) | Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung. | |
DE69622510T2 (de) | Nifedipinzubereitung mit langanhaltender Freisetzung | |
BG102228A (en) | Medicamentous form with controlled release of slightly soluble medicamentous substances | |
IL111400A0 (en) | Pharmaceutical compositions containing metroprolol and methods for the preparation thereof | |
AU4930197A (en) | Improved rapidly disintegratable multiparticulate tablet | |
NO820433L (no) | Legemiddelfrigivende preparat | |
ES2037082T3 (es) | Una composicion para la liberacion controlada de un farmaco. | |
NO870558L (no) | Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat. | |
IL111647A0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them | |
ES512393A0 (es) | "un procedimiento para preparar una composicion farmaceutica de liberacion mantenida a base de indoramin micronizado". | |
PT81039B (pt) | Processo para a preparacao de formulacoes constituidas por granulos esfericos | |
PT809512E (pt) | Solucoes farmaceuticas salinas nao inorganicas para administracao endonasal de uma calcitonina | |
DE3783923T3 (de) | Einen Wirkstoff und ein in Wasser quellendes Polymer enthaltendes Arzneimittel. | |
DE69634080D1 (de) | Mittel zur verhinderung der truebung der vorderen linsenkapsel | |
Gershbein | Effect of DL-ethionine and S-ethyl-L-cysteine on rat liver regeneration | |
KONDO et al. | Morphometry of abnormal peroxisomes induced by withdrawal of bezafibrate, a hypolipidemic drug in male rat hepatocytes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |